Skip to content

A randomized non-inferiority clinical trial comparing intrathecal morphine and erector spinae block for analgesia in living donors for liver transplantation

A randomized non-inferiority clinical trial comparing intrathecal morphine and erector spinae block for analgesia in living donors for liver transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003191
Enrollment
54
Registered
2018-09-20
Start date
2018-07-09
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Patients are randomly allocated to the 2 groups: the erector spinae plane block group and intrathecal morphine group.

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult (=19 years old or >19 years old) American society of anesthesiologist physical status I, II: healthy (I), controlled systemic disease (II)

Exclusion criteria

Exclusion criteria: American society of anesthesiologist physical status higher than III: uncontrolled systemic disease (III), severe systemic disease (IV), death (V) Child (<18 years old or =18 years old) Old Age (=70 years old or> 70 years old) Pregnancy Coagulopathy Unstable coronary artery disease, congestive heart failure, arrythmia, cardiomyopathy Cerebrovascular disease Systemic infection, infection at site of erector spinae plane block chronic pain disorder Refusal to study Allergy to local anesthetics Psychiatric disease

Design outcomes

Primary

MeasureTime frame
pain score at 24 hour postoperatively

Secondary

MeasureTime frame
Opioid consumption during the 24 h postoperatively

Countries

Korea, Republic of

Contacts

Public ContactRyungA Kang

Samsung Medical Center

ryunga.kang@gmail.com+82-2-3410-2470

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 20, 2026